ArticleCancer control : journal of the Moffitt Cancer Center
Denosumab as Second-Line Treatment in Patients With Metastatic Breast Cancer: A Retrospective Descriptive Pilot Study From a Single Institution.
Briana To et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.